BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
![Foto de BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS](/img/grupo.png)
![Foto de Center for Cancer and Blood Disorders](/img/noimage_org.png)
Center for Cancer and Blood Disorders
Fort Worth, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Center for Cancer and Blood Disorders (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477